JP2001505878A - 心臓血管剤としてのコノトキシンペプチドImIおよびMIIの使用 - Google Patents

心臓血管剤としてのコノトキシンペプチドImIおよびMIIの使用

Info

Publication number
JP2001505878A
JP2001505878A JP52373298A JP52373298A JP2001505878A JP 2001505878 A JP2001505878 A JP 2001505878A JP 52373298 A JP52373298 A JP 52373298A JP 52373298 A JP52373298 A JP 52373298A JP 2001505878 A JP2001505878 A JP 2001505878A
Authority
JP
Japan
Prior art keywords
conotoxin
mii
waves
neurons
imi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP52373298A
Other languages
English (en)
Japanese (ja)
Inventor
マッキントッシュ,ジェイ・マイケル
オリベラ,バルドメロ・エメ
ヨシカミ,ドジュ
Original Assignee
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション filed Critical ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション
Publication of JP2001505878A publication Critical patent/JP2001505878A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP52373298A 1996-11-18 1997-11-17 心臓血管剤としてのコノトキシンペプチドImIおよびMIIの使用 Pending JP2001505878A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3114196P 1996-11-18 1996-11-18
US60/031,141 1996-11-18
PCT/US1997/020669 WO1998022126A1 (en) 1996-11-18 1997-11-17 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS

Publications (1)

Publication Number Publication Date
JP2001505878A true JP2001505878A (ja) 2001-05-08

Family

ID=21857857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52373298A Pending JP2001505878A (ja) 1996-11-18 1997-11-17 心臓血管剤としてのコノトキシンペプチドImIおよびMIIの使用

Country Status (5)

Country Link
EP (1) EP0948346A4 (de)
JP (1) JP2001505878A (de)
AU (1) AU735724B2 (de)
CA (1) CA2271769A1 (de)
WO (1) WO1998022126A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2308115A1 (en) * 1997-10-24 1999-05-06 University Of Utah Research Foundation Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
US6797808B1 (en) * 1999-01-29 2004-09-28 University Of Utah Research Foundation α-conotoxin peptides
CA2743116C (en) * 1999-01-29 2016-06-21 University Of Utah Research Foundation Alpha-conotoxin peptides with a 4/7 motif
US7851444B2 (en) 2002-12-02 2010-12-14 Xenome Ltd. χ-conotoxin peptides (-1)
EP2386566A3 (de) 2002-12-02 2012-02-15 Xenome Ltd Chi-Conotoxin-Peptide (II)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189020A (en) * 1989-11-22 1993-02-23 Neurex Corporation Method of reducing neuronal damage using omega conotoxin peptides
GB2262886B (en) * 1991-12-17 1995-09-06 Lilly Industries Ltd N-channel calcium antagonists useful for treating bronchial diseases
US5514774A (en) * 1993-06-29 1996-05-07 University Of Utah Research Foundation Conotoxin peptides

Also Published As

Publication number Publication date
AU735724B2 (en) 2001-07-12
EP0948346A1 (de) 1999-10-13
EP0948346A4 (de) 2004-05-12
CA2271769A1 (en) 1998-05-28
AU5255598A (en) 1998-06-10
WO1998022126A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
Hoffer et al. Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenrtgic central inhibition
Ammons et al. Vagal afferent inhibition of primate thoracic spinothalamic neurons
Cannon et al. Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat
Ennis et al. Projections from the periaqueductal gray to the rostromedial pericoerulear region and nucleus locus coeruleus: anatomic and physiologic studies
Dingledine Possible mechanisms of enkephalin action on hippocampal CA1 pyramidal neurons
Robinson et al. Hyperpolarization-activated cation currents: from molecules to physiological function
Kuffler et al. Peptidergic and muscarinic excitation at amphibian sympathetic synapses.
Fields et al. Evidence that raphe-spinal neurons mediate opiate and midbrain stimulation-produced analgesias
Morita et al. Opiates and enkephalin reduce the excitability of neuronal processes
Hill et al. Depression of nociceptive and other neurones in the brain by iontophoretically applied met-enkephalin
Hamburg et al. Chronic morphine administration increases the apparent number of α 2-adrenergic receptors in rat brain
TAKAGI et al. The effect of analgesics on the spinal reflex activity of the cat
Renaud An electrophysiological study of amygdalohypothalamic projections to the ventromedial nucleus of the rat
Voisin et al. Central inhibitory effects of muscimol and bicuculline on the milk ejection reflex in the anaesthetized rat.
Zhang et al. Locus coeruleus stimulation modulates the nociceptive response in parafascicular neurons: an analysis of descending and ascending pathways
Hoskin et al. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat
JP2001505878A (ja) 心臓血管剤としてのコノトキシンペプチドImIおよびMIIの使用
Tebēcis Cholinergic and non‐cholinergic transmission in the medial geniculate nucleus of the cat
Feldberg Rapport N° 2 Some Aspects in Pharmacology of Central Synaptic Transmission
Kamogawa et al. Inhibitory input to pause neurons from pontine burst neuron area in the cat
Jänig et al. Receptive properties of pial afferents
Acosta-Urquidi et al. The effects of Δ9-tetrahydrocannabinol on action potentials in the mollusc Aplysia
Li et al. Suppression of nociceptive responses in parafascicular neurons by stimulation of substantia nigra: an analysis of related inhibitory pathways
Hill et al. Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog
Xia et al. INHIBITORY EFFECT OF ANAL0G0US ELECTRO-ACUPUNCTURE ON EXPERIMENTAL ARRYTHMIA